Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • VXUS vs GSK✓SelectedUSD · GSKVXUS vs GSK performance historyLatest closeAs of-2.00%11/16
Stock and ETF performance explorer

VXUS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+43.5%
GSK return
+46.9%
Excess return
-3.4%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.0%-0.1%-1.9%-2.0%
7D-2.7%-1.3%-1.4%-2.4%
30D-2.9%+2.7%-5.7%-3.5%
3M-7.5%+2.7%-10.2%-8.2%
6M-1.9%+3.3%-5.3%-3.1%
YTD+8.1%+6.5%+1.7%+6.0%
1Y+10.9%+10.7%+0.2%+7.6%
3Y+61.0%+64.4%-3.3%+38.5%
5Y+43.5%+46.7%-3.2%+19.4%
All+43.5%+46.9%-3.4%+19.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling